Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00523874
Other study ID # R00126
Secondary ID
Status Completed
Phase N/A
First received August 31, 2007
Last updated August 31, 2007
Start date January 2001
Est. completion date May 2007

Study information

Verified date January 2001
Source University of Tampere
Contact n/a
Is FDA regulated No
Health authority Finland: Ethical commettee of Federatio of Municipalities in the Hospital District of Pirkanmaa and National Authority for Medicolegal Affairs
Study type Observational

Clinical Trial Summary

Previously our retrospective study showed that almost half of the patients with acute alcoholic pancreatitis had a recurrent attack in the long-term, mild pancreatitis and young age being risk factors for recurrence. The aim of this prospective follow-up study was aimed to find out the risk factors in detail.


Description:

Patients admitted to Tampere University Hospital for first acute alcoholic pancreatitis were included. The diagnostic criteria for acute pancreatitis were epigastric pain, serum amylase > 3 x upper normal range, elevated serum CRP and signs of acute pancreatitis in imaging. Other etiologies were excluded. Alcohol consumption and dependency were detected. Serum and fecal markers of the endocrine and exocrine function and secretin stimulated MRCP were studied. The patients were followed median 38 (25 - 61) months for the recurrences and had a follow up visit at two years to investigate trends in the alcohol consumption.


Recruitment information / eligibility

Status Completed
Enrollment 120
Est. completion date May 2007
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients who survived their first acute alcoholic pancreatitis. The diagnostic criteria for acute pancreatitis were epigastric pain, serum amylase > 3 x upper normal range, elevated serum CRP and signs of acute pancreatitis in imaging. Other etiologies were excluded.

- High alcohol consumption was detected

Study Design

Observational Model: Defined Population, Primary Purpose: Screening, Time Perspective: Longitudinal


Related Conditions & MeSH terms


Locations

Country Name City State
Finland Tampere University Hospital Tampere

Sponsors (1)

Lead Sponsor Collaborator
University of Tampere

Country where clinical trial is conducted

Finland, 

See also
  Status Clinical Trial Phase
Completed NCT01583517 - ERCP in Idiopathic Recurrent Acute Pancreatitis N/A
Recruiting NCT06185621 - The Effect of Aspirin on Recurrent Acute Pancreatitis N/A
Recruiting NCT04647097 - Preventing the Recurrence of Acute Pancreatitis by Alcohol and Smoking Cessation N/A
Not yet recruiting NCT06253117 - Evaluation of Pirfenidone as a Novel Therapeutic Strategy Against Recurrent Acute Pancreatitis. Phase 2
Not yet recruiting NCT05453851 - A Surgical Procedure (Total Pancreatectomy) With a Transplant Procedure (Islet Cell Autotransplantation) for the Treatment of Chronic Pancreatitis and Benign Pancreatic Tumors Phase 1/Phase 2
Not yet recruiting NCT05771675 - Simvastatin Treatment to Improve Patient-reported Outcomes in Patients With Chronic Pancreatitis Early Phase 1
Recruiting NCT06355206 - Natural Course and Therapeutic Effect of Recurrent Acute Pancreatitis
Not yet recruiting NCT06364397 - Efficacy of ERCP in the Diagnosis and Treatment of Idiopathic Recurrent Acute Pancreatitis N/A